ROYAL BANK OF CANADA - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$555,000
+27.3%
11,073
+60.5%
0.00%
Q2 2023$436,000
+50.3%
6,899
+6.8%
0.00%
Q1 2023$290,000
-45.8%
6,458
-47.2%
0.00%
Q4 2022$535,000
+117.5%
12,241
+227.1%
0.00%
Q3 2022$246,000
+2.9%
3,742
-20.9%
0.00%
Q2 2022$239,000
-50.6%
4,732
-37.6%
0.00%
Q1 2022$484,000
-74.7%
7,579
-57.6%
0.00%
Q4 2021$1,914,000
+104.9%
17,872
+96.8%
0.00%
Q3 2021$934,000
-59.3%
9,080
-65.2%
0.00%
-100.0%
Q2 2021$2,296,000
-54.7%
26,111
-49.9%
0.00%0.0%
Q1 2021$5,065,000
-19.7%
52,088
-7.3%
0.00%
-50.0%
Q4 2020$6,304,000
+22.1%
56,198
+0.9%
0.00%0.0%
Q3 2020$5,161,000
-6.4%
55,680
-21.2%
0.00%0.0%
Q2 2020$5,514,000
+37.2%
70,690
+2.8%
0.00%0.0%
Q1 2020$4,020,000
+545.3%
68,747
+782.7%
0.00%
Q4 2019$623,000
+165.1%
7,788
+143.8%
0.00%
Q3 2019$235,000
-87.5%
3,195
-84.0%
0.00%
-100.0%
Q2 2019$1,879,000
-17.4%
19,925
-29.9%
0.00%0.0%
Q1 2019$2,274,000
-61.6%
28,406
-74.2%
0.00%
-66.7%
Q4 2018$5,925,000
-27.2%
109,921
+5.3%
0.00%0.0%
Q3 2018$8,144,000
+70.4%
104,347
+38.6%
0.00%
+50.0%
Q2 2018$4,780,000
+95500.0%
75,299
+141973.6%
0.00%
Q1 2018$5,000
-78.3%
53
-83.0%
0.00%
Q4 2017$23,000
-99.7%
312
-99.7%
0.00%
-100.0%
Q3 2017$8,292,000
+138100.0%
119,025
+96668.3%
0.00%
Q2 2017$6,000
-76.9%
123
-80.9%
0.00%
Q1 2017$26,000
+13.0%
643
-22.2%
0.00%
Q4 2016$23,000827
+6261.5%
0.00%
Q4 2015$0
-100.0%
13
-96.9%
0.00%
Q3 2015$9,000
-40.0%
419
-27.0%
0.00%
Q2 2015$15,0005740.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders